UK study digs into CMV infection patterns in kidney transplant patients
NCT ID NCT06568055
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviewed medical records of 330 kidney transplant patients in the UK to understand how cytomegalovirus (CMV) infections are managed. Researchers looked at how common these infections are, what treatments were used, and how well they worked. The goal was to gather information to improve future care, without changing any patient's treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RaDaR (part of the UK Kidney Association)
Bristol, Southwestern England, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Better CMV detection for IBD patients: which test works best?
- New study checks if maribavir works safely for transplant patients with stubborn CMV
- New hope for young transplant patients: maribavir trial targets CMV
- New trial aims to stop CMV eye inflammation from returning
- New hope for transplant patients with Drug-Resistant CMV
- Maribavir safety under review for kidney patients with CMV